Zimvie Inc Quick Ratio (ZIMV) starting from the second quarter 2025 to second quarter 2024, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Zimvie Inc   (NASDAQ: ZIMV)

Zimvie Inc 's Quick Ratio

ZIMV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Zimvie Inc 's Cash & cash equivalent grew by 5.13 % in the Q2 2025 sequentially, while Current Liabilities decreased, this led to improvement in Zimvie Inc 's Quick Ratio to 0.64 a new company high.

Within Medical Equipment & Supplies industry 119 other companies have achieved higher Quick Ratio than Zimvie Inc in second quarter 2025. While Quick Ratio total ranking in the second quarter 2025 has deteriorated compared to the prior quarter from 1616 to 1871.

Explain Quick Ratio?
How much Cash & cash equivalents ZIMV´s has?
What are ZIMV´s Current Liabilities?




ZIMV Quick Ratio (Jun 30 2025)
Q2
(Mar 31 2025)
Q1
(Dec 31 2024)
Q4
(Sep 30 2024)
Q3
(Jun 30 2024)
Q2
Y / Y Current Liabilities Change -22.33 % -30.95 % -22.85 % -20.2 % -25.62 %
Y / Y Cash & cash equivalent Change -10.72 % 53.35 % 4.84 % -11.45 % 18.71 %
Quick Ratio MRQ 0.64 0.57 0.56 0.49 0.56
ZIMV's Total Ranking # 1871 # 1616 # 783 # 2215 # 2052
Seq. Current Liabilities Change -6.43 % -12.54 % -1.97 % -3.18 % -16.81 %
Seq. Cash & cash equivalent Change 5.13 % -10.97 % 12.22 % -15 % 80.58 %



Quick Ratio second quarter 2025 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 120
Healthcare Sector # 652
Overall Market # 1871


Quick Ratio Statistics
High Average Low
0.64 0.48 0.26
(Jun 30 2025)   (Mar 31 2024)




Financial Statements
Zimvie Inc 's Current Liabilities $ 110 Millions Visit ZIMV's Balance sheet
Zimvie Inc 's Cash & cash equivalent $ 70 Millions Visit ZIMV's Balance sheet
Source of ZIMV's Sales Visit ZIMV's Sales by Geography


Cumulative Zimvie Inc 's Quick Ratio

ZIMV's Quick Ratio for the trailling 12 Months

ZIMV Quick Ratio

(Jun 30 2025)
12 Months
(Mar 31 2025)
12 Months
(Dec 31 2024)
12 Months
(Sep 30 2024)
12 Months
(Jun 30 2024)
12 Months
Y / Y Current Liabilities TTM Growth -24.14 % -24.9 % -20.48 % -16.4 % -16.92 %
Y / Y Cash & cash equivalent TTM Growth 3.57 % 11.86 % -5.61 % -5.75 % -15.09 %
Quick Ratio TTM 0.56 0.54 0.45 0.42 0.41
Total Ranking TTM # 3251 # 3240 # 1374 # 3438 # 3206
Seq. Current Liabilities TTM Growth -5.96 % -9.03 % -6.39 % -5.27 % -6.9 %
Seq. Cash & cash equivalent TTM Growth -2.93 % 8.8 % 1.33 % -3.21 % 4.83 %


On the trailing twelve months basis Current Liabilities decreased faster than Zimvie Inc 's average Cash & cash equivalent, this led to increase in in Zimvie Inc 's Quick Ratio to 0.56, above ZIMV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 190 other companies have achieved higher Quick Ratio than Zimvie Inc . While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the first quarter 2025 from 3240 to 3251.

Explain Quick Ratio?
How much Cash & cash equivalents ZIMV´s has?
What are ZIMV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 191
Healthcare Sector # 866
Within the Market # 3251


trailing twelve months Quick Ratio Statistics
High Average Low
0.56 0.45 0.36
(Jun 30 2025)   (Mar 31 2024)




Companies with similar Quick Ratio in the quarter ending Jun 30 2025, within Medical Equipment & Supplies Industry Quick RatioJun 30 2025 MRQ Cash & cash equivalentJun 30 2025 MRQ Current Liabilities
Atricure Inc   1.71 $ 117.796  Millions$ 68.843  Millions
Surmodics Inc   1.68 $ 32.728  Millions$ 19.441  Millions
Adagio Medical Holdings inc   1.68 $ 8.200  Millions$ 4.884  Millions
Treace Medical Concepts Inc   1.65 $ 69.289  Millions$ 41.900  Millions
Merit Medical Systems Inc  1.59 $ 341.819  Millions$ 215.310  Millions
Electromed Inc   1.46 $ 15.287  Millions$ 10.468  Millions
Si bone inc   1.44 $ 34.150  Millions$ 23.644  Millions
Valion Bio Inc   1.44 $ 1.184  Millions$ 0.821  Millions
Inspira Technologies Oxy B H N Ltd  1.43 $ 2.126  Millions$ 1.487  Millions
Envista Holdings Corporation  1.40 $ 1,110.600  Millions$ 793.900  Millions
Beyond Air Inc   1.40 $ 6.463  Millions$ 4.626  Millions
Novocure Limited  1.37 $ 911.525  Millions$ 663.468  Millions
Livanova Plc  1.36 $ 593.638  Millions$ 436.201  Millions
Koru Medical Systems Inc   1.33 $ 8.055  Millions$ 6.051  Millions
Myomo Inc   1.32 $ 15.482  Millions$ 11.754  Millions
Axogen inc   1.31 $ 29.922  Millions$ 22.770  Millions
Jin Medical International Ltd  1.26 $ 29.630  Millions$ 23.507  Millions
Seastar Medical Holding Corp  1.25 $ 6.302  Millions$ 5.041  Millions
Resmed Inc   1.19 $ 1,209.450  Millions$ 1,019.120  Millions
Safe Pro Group Inc   1.17 $ 0.806  Millions$ 0.687  Millions
Electrocore Inc   1.15 $ 11.172  Millions$ 9.725  Millions
Nuwellis Inc   1.14 $ 4.450  Millions$ 3.892  Millions
Sanara Medtech Inc   1.14 $ 16.959  Millions$ 14.876  Millions
Allurion Technologies Inc   1.10 $ 12.722  Millions$ 11.616  Millions
Lifeward ltd   1.07 $ 10.278  Millions$ 9.630  Millions
Lucid Diagnostics Inc   1.06 $ 31.123  Millions$ 29.426  Millions
Docgo Inc   1.04 $ 104.164  Millions$ 100.147  Millions
West Pharmaceutical Services Inc   1.04 $ 509.700  Millions$ 490.300  Millions
Cytosorbents Corporation  1.04 $ 10.204  Millions$ 9.842  Millions
Fractyl Health Inc   1.02 $ 22.291  Millions$ 21.832  Millions

Date modified: 2026-09-18T13:11:06+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.